Bio-techne Corp. (TECH) live share price

Bio-techne Corp. share price in USD $75.36 & INR ₹6,382.62

$75.36

▲

-0.02

(-0.03%)

View live Bio-techne Corp. share price in Dollar and Rupees. Guide to invest in Bio-techne Corp. from India. Also see the sentimental analysis on Indian investors investing in Bio-techne Corp.. Get details on the Indian mutual funds that are investing in Bio-techne Corp.. Get Analyst recommendations and forecasts along with all the Bio-techne Corp.'s financials.

Bio-techne Corp. share price movements

$74.70
$75.87
$75.36
0.88%
Downside
Day's Volatility :1.54%
Upside
0.67%
$61.16
$85.57
$75.36
18.84%
Downside
52 Weeks Volatility :28.53%
Upside
11.93%

Bio-techne Corp. Returns

Period	Bio-techne Corp.	Sector (Health Care)	S&P500
3 Months	5.06%	-6.2%	6.8%
6 Months	-3.26%	2.6%	14.3%
1 Year	15.41%	11.8%	31.3%
3 Years	-33.92%	13.3%	31.8%

Bio-techne Corp. Key Statistics

in dollars & INR

Market Capitalization	$12.0B
Revenue TTM	$1.2B
EBITDA	$308.5M
Earnings Per Share (EPS)	$0.95
PE Ratio	79.35
Dividend Yield	0.42%
Profit Margin	12.86%
Quarterly Earnings Growth YOY	-0.32%
Return On Equity TTM	7.29%

How to invest in Bio-techne Corp. from India?

It is very easy for Indian residents to invest directly in Bio-techne Corp. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bio-techne Corp. stock in both rupees (INR) and dollars (USD). Search for Bio-techne Corp. or TECH on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bio-techne Corp. or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bio-techne Corp. shares which would translate to 0.011 fractional shares of Bio-techne Corp. as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Bio-techne Corp.

-7%

Period: Sep 2, 2024 to Dec 1, 2024. Change in 30 Days versus previous period

Search volume for Bio-techne Corp. on INDmoney from India has reduced in the last 30 days as on Dec 2, 2024. -7% less investors are searching Bio-techne Corp. in the last 30 days versus the previous period.

Indian Mutual Funds that own Bio-techne Corp.

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	1354	-2.46	0.02%

Global Institutional Holdings in Bio-techne Corp.

Vanguard Group Inc
11.53%
BlackRock Inc
9.43%
Morgan Stanley - Brokerage Accounts
5.55%
T. Rowe Price Associates, Inc.
5.37%
State Street Corp
3.97%
BAMCO Inc
2.80%

Analyst Recommendation on Bio-techne Corp.

Buy

84%Buy

15%Hold

0%Sell

Based on 19 Wall street analysts offering stock ratings for Bio-techne Corp.(by analysts ranked 0 to 5 stars)

Based on 19 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Bio-techne Corp.

What analysts predicted

Upside of 13.12%

Current:

$75.36

Target:

$85.25

Insights on Bio-techne Corp.

Decreasing Revenue
Revenue is down for the last 2 quarters, 306.09M → 289.45M (in $), with an average decrease of 5.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 49.05M → 33.6M (in $), with an average decrease of 17.2% per quarter
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 47.6% return, outperforming this stock by 30.9%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.4% return, outperforming this stock by 73.9%

Bio-techne Corp. Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$714.0M	↑ 11.04%
Net Income	$96.1M	↓ 23.36%
Net Profit Margin	13.46%	↓ 6.03%

	FY20	Y/Y Change
Revenue	$738.7M	↑ 3.46%
Net Income	$229.3M	↑ 138.67%
Net Profit Margin	31.04%	↑ 17.58%

	FY21	Y/Y Change
Revenue	$931.0M	↑ 26.04%
Net Income	$140.4M	↓ 38.76%
Net Profit Margin	15.08%	↓ 15.96%

	FY22	Y/Y Change
Revenue	$1.1B	↑ 18.75%
Net Income	$272.1M	↑ 93.75%
Net Profit Margin	24.61%	↑ 9.53%

	FY23	Y/Y Change
Revenue	$1.1B	↑ 2.81%
Net Income	$285.3M	↑ 4.86%
Net Profit Margin	25.1%	↑ 0.49%

	FY24	Y/Y Change
Revenue	$1.2B	↑ 1.97%
Net Income	$168.1M	↓ 41.07%
Net Profit Margin	14.5%	↓ 10.6%

	Q2 FY23	Q/Q Change
Revenue	$301.3M	↑ 2.44%
Net Income	$75.5M	↑ 7.5%
Net Profit Margin	25.05%	↑ 1.18%

	Q3 FY23	Q/Q Change
Revenue	$276.9M	↓ 8.09%
Net Income	$51.0M	↓ 32.45%
Net Profit Margin	18.41%	↓ 6.64%

	Q4 FY23	Q/Q Change
Revenue	$272.6M	↓ 1.57%
Net Income	$27.5M	↓ 46.14%
Net Profit Margin	10.08%	↓ 8.33%

	Q1 FY24	Q/Q Change
Revenue	$303.4M	↑ 11.31%
Net Income	$49.1M	↑ 78.62%
Net Profit Margin	16.17%	↑ 6.09%

	Q2 FY24	Q/Q Change
Revenue	$306.1M	↑ 0.88%
Net Income	$40.6M	↓ 17.27%
Net Profit Margin	13.26%	↓ 2.91%

	Q3 FY24	Q/Q Change
Revenue	$289.5M	↓ 5.44%
Net Income	$33.6M	↓ 17.22%
Net Profit Margin	11.61%	↓ 1.65%

	FY19	Y/Y Change
Total Assets	$1.9B	↑ 18.28%
Total Liabilities	$718.8M	↑ 39.83%

	FY20	Y/Y Change
Total Assets	$2.0B	↑ 7.6%
Total Liabilities	$646.4M	↓ 10.08%

	FY21	Y/Y Change
Total Assets	$2.3B	↑ 11.61%
Total Liabilities	$691.7M	↑ 7.01%

	FY22	Y/Y Change
Total Assets	$2.3B	↑ 1.41%
Total Liabilities	$593.8M	↓ 14.16%

	FY23	Y/Y Change
Total Assets	$2.6B	↑ 14.99%
Total Liabilities	$672.2M	↑ 13.2%

	FY24	Y/Y Change
Total Assets	$2.7B	↑ 2.47%
Total Liabilities	$635.0M	↓ 5.53%

	Q2 FY23	Q/Q Change
Total Assets	$2.6B	↑ 1.5%
Total Liabilities	$672.2M	↓ 5.33%

	Q3 FY23	Q/Q Change
Total Assets	$2.8B	↑ 4.42%
Total Liabilities	$757.6M	↑ 12.71%

	Q4 FY23	Q/Q Change
Total Assets	$2.7B	↓ 0.89%
Total Liabilities	$767.2M	↑ 1.26%

	Q1 FY24	Q/Q Change
Total Assets	$2.7B	↓ 0.35%
Total Liabilities	$706.8M	↓ 7.87%

	Q2 FY24	Q/Q Change
Total Assets	$2.8B	↑ 3.38%
Total Liabilities	$744.3M	↑ 5.31%

	Q3 FY24	Q/Q Change
Total Assets	$2.7B	↓ 2.74%
Total Liabilities	$597.4M	↓ 19.75%

	FY19	Y/Y Change
Operating Cash Flow	$181.6M	↑ 6.6%
Investing Cash Flow	$-336.8M	↑ 770.01%
Financing Cash Flow	$134.4M	↓ 235.48%

	FY20	Y/Y Change
Operating Cash Flow	$205.2M	↑ 12.99%
Investing Cash Flow	$27.1M	↓ 108.04%
Financing Cash Flow	$-183.8M	↓ 236.77%

	FY21	Y/Y Change
Operating Cash Flow	$352.2M	↑ 71.61%
Investing Cash Flow	$-243.5M	↓ 998.75%
Financing Cash Flow	$-62.6M	↓ 65.97%

	FY22	Y/Y Change
Operating Cash Flow	$325.3M	↓ 7.64%
Investing Cash Flow	$-96.9M	↓ 60.23%
Financing Cash Flow	$-242.9M	↑ 288.25%

	FY23	Y/Y Change
Operating Cash Flow	$254.4M	↓ 21.79%
Investing Cash Flow	$-265.6M	↑ 174.29%
Financing Cash Flow	$22.6M	↓ 109.31%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$83.4M	↑ 65.02%
Investing Cash Flow	$-4.8M	↓ 98.03%
Financing Cash Flow	$-24.2M	↓ 116.06%

Bio-techne Corp. Technicals Summary

Sell

Neutral

Buy

Bio-techne Corp. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Bio-techne Corp. Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bio-techne Corp.	-0.71%	-3.26%	15.41%	-33.92%	38.03%
Regeneron Pharmaceuticals, Inc.	-9.49%	-24.18%	-8.88%	18.12%	102.78%
Biontech Se	8.64%	15.09%	18.5%	-65.59%	454.0%
Alnylam Pharmaceuticals, Inc.	-6.25%	68.21%	46.39%	47.68%	107.47%
Vertex Pharmaceuticals Incorporated	-0.99%	-0.44%	33.51%	129.69%	109.07%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bio-techne Corp.	79.35	79.35	2.77	1.78	0.07	0.06	0.0	13.46
Regeneron Pharmaceuticals, Inc.	18.66	18.66	1.12	44.91	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.22	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bio-techne Corp.	Buy	$12.0B	38.03%	79.35	12.86%
Regeneron Pharmaceuticals, Inc.	Buy	$83.0B	102.78%	18.66	33.61%
Biontech Se	Buy	$28.9B	454.0%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	107.47%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$119.6B	109.07%	32.84	-4.51%

Bio-techne Corp. Dividend announcements

Bio-techne Corp. Dividends June, 2024
In the quarter ending June,2024. Bio-techne Corp. has declared dividend of $0.08
Read More

About Bio-techne Corp.

bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. with over 275,000 products in its portfolio, bio-techne generated approximately $358 million in net sales in fy 2014 and has over 1,000 employees worldwide.

Organization	Bio-techne Corp.
Employees	3100
CEO	Mr. Kim Kelderman
Industry	Health Technology

Important FAQs about investing in Bio-techne Corp. from India :

What is Bio-techne Corp. share price today?

Bio-techne Corp. (TECH) share price today is $75.36.

Can Indians buy Bio-techne Corp. shares?

Yes, Indians can invest in the Bio-techne Corp. (TECH) from India.

With INDmoney, you can buy Bio-techne Corp. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Bio-techne Corp. at zero transaction cost.

How can I buy Bio-techne Corp. shares from India?

It is very easy to buy Bio-techne Corp. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bio-techne Corp. be purchased?

Yes, you can buy fractional shares of Bio-techne Corp. with INDmoney app.

What are the documents required to start investing in Bio-techne Corp. stocks?

To start investing in Bio-techne Corp., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.